FILTERED RESULTS
FILTERS
Ads Top
DARK MODE
CHART
    Filters
      Symbols
      Sentiment
      Impact
      Search
      FILTERED RESULTS

        

      Upgrade your plan

      Gilead Sciences and Tempus AI Expand Oncology Research Collaboration

      Gilead Sciences Inc. has announced an expansion of its multi-year collaboration with Tempus AI aimed at enhancing oncology research. This partnership is designed to leverage Tempus' advanced technology and data analytics capabilities to accelerate the development of innovative cancer therapies.

      The collaboration will focus on utilizing Tempus' extensive genomic and clinical data to support Gilead's ongoing research initiatives in oncology. This strategic alliance reflects Gilead's commitment to advancing cancer treatment options and improving patient outcomes through cutting-edge research and development efforts.

      © 2026 KLEA News. All Rights Reserved. This article is provided for informational purposes only. It is not offered or intended to be used as legal, tax, investment, financial, or other advice.

      Source: KLEA News

      .

      Terra Founder Do Kwon Sentenced to 15 Years in Prison for Fraud